Copyright Reports & Markets. All rights reserved.

Global Circulating Tumor DNA Test Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Circulating Tumor DNA Test Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Blood Cancer
    • 1.3.3 Solid Tumor
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Circulating Tumor DNA Test Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Circulating Tumor DNA Test Kit Market Size & Forecast
    • 1.5.1 Global Circulating Tumor DNA Test Kit Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Circulating Tumor DNA Test Kit Sales Quantity (2021-2032)
    • 1.5.3 Global Circulating Tumor DNA Test Kit Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Grail, Inc.
    • 2.1.1 Grail, Inc. Details
    • 2.1.2 Grail, Inc. Major Business
    • 2.1.3 Grail, Inc. Circulating Tumor DNA Test Kit Product and Services
    • 2.1.4 Grail, Inc. Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Grail, Inc. Recent Developments/Updates
  • 2.2 Guardant Health, Inc.
    • 2.2.1 Guardant Health, Inc. Details
    • 2.2.2 Guardant Health, Inc. Major Business
    • 2.2.3 Guardant Health, Inc. Circulating Tumor DNA Test Kit Product and Services
    • 2.2.4 Guardant Health, Inc. Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Guardant Health, Inc. Recent Developments/Updates
  • 2.3 Biodesix, Inc.
    • 2.3.1 Biodesix, Inc. Details
    • 2.3.2 Biodesix, Inc. Major Business
    • 2.3.3 Biodesix, Inc. Circulating Tumor DNA Test Kit Product and Services
    • 2.3.4 Biodesix, Inc. Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Biodesix, Inc. Recent Developments/Updates
  • 2.4 Exosome Diagnostics
    • 2.4.1 Exosome Diagnostics Details
    • 2.4.2 Exosome Diagnostics Major Business
    • 2.4.3 Exosome Diagnostics Circulating Tumor DNA Test Kit Product and Services
    • 2.4.4 Exosome Diagnostics Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Exosome Diagnostics Recent Developments/Updates
  • 2.5 Freenome Inc.
    • 2.5.1 Freenome Inc. Details
    • 2.5.2 Freenome Inc. Major Business
    • 2.5.3 Freenome Inc. Circulating Tumor DNA Test Kit Product and Services
    • 2.5.4 Freenome Inc. Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Freenome Inc. Recent Developments/Updates
  • 2.6 LungLife AI, Inc.
    • 2.6.1 LungLife AI, Inc. Details
    • 2.6.2 LungLife AI, Inc. Major Business
    • 2.6.3 LungLife AI, Inc. Circulating Tumor DNA Test Kit Product and Services
    • 2.6.4 LungLife AI, Inc. Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 LungLife AI, Inc. Recent Developments/Updates
  • 2.7 Inivata Ltd.
    • 2.7.1 Inivata Ltd. Details
    • 2.7.2 Inivata Ltd. Major Business
    • 2.7.3 Inivata Ltd. Circulating Tumor DNA Test Kit Product and Services
    • 2.7.4 Inivata Ltd. Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Inivata Ltd. Recent Developments/Updates
  • 2.8 Personal Genome Diagnostics, Inc.
    • 2.8.1 Personal Genome Diagnostics, Inc. Details
    • 2.8.2 Personal Genome Diagnostics, Inc. Major Business
    • 2.8.3 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Product and Services
    • 2.8.4 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Personal Genome Diagnostics, Inc. Recent Developments/Updates
  • 2.9 CellMax Life
    • 2.9.1 CellMax Life Details
    • 2.9.2 CellMax Life Major Business
    • 2.9.3 CellMax Life Circulating Tumor DNA Test Kit Product and Services
    • 2.9.4 CellMax Life Circulating Tumor DNA Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CellMax Life Recent Developments/Updates

3 Competitive Environment: Circulating Tumor DNA Test Kit by Manufacturer

  • 3.1 Global Circulating Tumor DNA Test Kit Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Circulating Tumor DNA Test Kit Revenue by Manufacturer (2021-2026)
  • 3.3 Global Circulating Tumor DNA Test Kit Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Circulating Tumor DNA Test Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Circulating Tumor DNA Test Kit Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Circulating Tumor DNA Test Kit Manufacturer Market Share in 2025
  • 3.5 Circulating Tumor DNA Test Kit Market: Overall Company Footprint Analysis
    • 3.5.1 Circulating Tumor DNA Test Kit Market: Region Footprint
    • 3.5.2 Circulating Tumor DNA Test Kit Market: Company Product Type Footprint
    • 3.5.3 Circulating Tumor DNA Test Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Circulating Tumor DNA Test Kit Market Size by Region
    • 4.1.1 Global Circulating Tumor DNA Test Kit Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Circulating Tumor DNA Test Kit Consumption Value by Region (2021-2032)
    • 4.1.3 Global Circulating Tumor DNA Test Kit Average Price by Region (2021-2032)
  • 4.2 North America Circulating Tumor DNA Test Kit Consumption Value (2021-2032)
  • 4.3 Europe Circulating Tumor DNA Test Kit Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Circulating Tumor DNA Test Kit Consumption Value (2021-2032)
  • 4.5 South America Circulating Tumor DNA Test Kit Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Circulating Tumor DNA Test Kit Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Circulating Tumor DNA Test Kit Sales Quantity by Type (2021-2032)
  • 5.2 Global Circulating Tumor DNA Test Kit Consumption Value by Type (2021-2032)
  • 5.3 Global Circulating Tumor DNA Test Kit Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Circulating Tumor DNA Test Kit Sales Quantity by Application (2021-2032)
  • 6.2 Global Circulating Tumor DNA Test Kit Consumption Value by Application (2021-2032)
  • 6.3 Global Circulating Tumor DNA Test Kit Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Circulating Tumor DNA Test Kit Sales Quantity by Type (2021-2032)
  • 7.2 North America Circulating Tumor DNA Test Kit Sales Quantity by Application (2021-2032)
  • 7.3 North America Circulating Tumor DNA Test Kit Market Size by Country
    • 7.3.1 North America Circulating Tumor DNA Test Kit Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Circulating Tumor DNA Test Kit Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Circulating Tumor DNA Test Kit Sales Quantity by Type (2021-2032)
  • 8.2 Europe Circulating Tumor DNA Test Kit Sales Quantity by Application (2021-2032)
  • 8.3 Europe Circulating Tumor DNA Test Kit Market Size by Country
    • 8.3.1 Europe Circulating Tumor DNA Test Kit Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Circulating Tumor DNA Test Kit Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Circulating Tumor DNA Test Kit Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Circulating Tumor DNA Test Kit Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Circulating Tumor DNA Test Kit Market Size by Region
    • 9.3.1 Asia-Pacific Circulating Tumor DNA Test Kit Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Circulating Tumor DNA Test Kit Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Circulating Tumor DNA Test Kit Sales Quantity by Type (2021-2032)
  • 10.2 South America Circulating Tumor DNA Test Kit Sales Quantity by Application (2021-2032)
  • 10.3 South America Circulating Tumor DNA Test Kit Market Size by Country
    • 10.3.1 South America Circulating Tumor DNA Test Kit Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Circulating Tumor DNA Test Kit Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Circulating Tumor DNA Test Kit Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Circulating Tumor DNA Test Kit Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Circulating Tumor DNA Test Kit Market Size by Country
    • 11.3.1 Middle East & Africa Circulating Tumor DNA Test Kit Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Circulating Tumor DNA Test Kit Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Circulating Tumor DNA Test Kit Market Drivers
  • 12.2 Circulating Tumor DNA Test Kit Market Restraints
  • 12.3 Circulating Tumor DNA Test Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Circulating Tumor DNA Test Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Circulating Tumor DNA Test Kit
  • 13.3 Circulating Tumor DNA Test Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Circulating Tumor DNA Test Kit Typical Distributors
  • 14.3 Circulating Tumor DNA Test Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Circulating Tumor DNA Test Kit market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    During the process of tumor cell proliferation and constant cell cycle transformation, tumor DNA fragments can enter the bloodstream. These tumor DNA fragments in the bloodstream are tumor circulating DNA, or ctDNA for short.
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    This report is a detailed and comprehensive analysis for global Circulating Tumor DNA Test Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Circulating Tumor DNA Test Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Circulating Tumor DNA Test Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Circulating Tumor DNA Test Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Circulating Tumor DNA Test Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Circulating Tumor DNA Test Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Circulating Tumor DNA Test Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grail, Inc., Guardant Health, Inc., Biodesix, Inc., Exosome Diagnostics, Freenome Inc., LungLife AI, Inc., Inivata Ltd., Personal Genome Diagnostics, Inc., CellMax Life, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Circulating Tumor DNA Test Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Blood Cancer
    Solid Tumor
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Grail, Inc.
    Guardant Health, Inc.
    Biodesix, Inc.
    Exosome Diagnostics
    Freenome Inc.
    LungLife AI, Inc.
    Inivata Ltd.
    Personal Genome Diagnostics, Inc.
    CellMax Life
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Circulating Tumor DNA Test Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Circulating Tumor DNA Test Kit, with price, sales quantity, revenue, and global market share of Circulating Tumor DNA Test Kit from 2021 to 2026.
    Chapter 3, the Circulating Tumor DNA Test Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Circulating Tumor DNA Test Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Circulating Tumor DNA Test Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Circulating Tumor DNA Test Kit.
    Chapter 14 and 15, to describe Circulating Tumor DNA Test Kit sales channel, distributors, customers, research findings and conclusion.

    Buy now